Marco Witkowski

2.5k total citations · 3 hit papers
29 papers, 1.6k citations indexed

About

Marco Witkowski is a scholar working on Cardiology and Cardiovascular Medicine, Hematology and Molecular Biology. According to data from OpenAlex, Marco Witkowski has authored 29 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 9 papers in Hematology and 8 papers in Molecular Biology. Recurrent topics in Marco Witkowski's work include Blood Coagulation and Thrombosis Mechanisms (9 papers), Antiplatelet Therapy and Cardiovascular Diseases (6 papers) and Atrial Fibrillation Management and Outcomes (5 papers). Marco Witkowski is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (9 papers), Antiplatelet Therapy and Cardiovascular Diseases (6 papers) and Atrial Fibrillation Management and Outcomes (5 papers). Marco Witkowski collaborates with scholars based in Germany, United States and Sweden. Marco Witkowski's co-authors include Stanley L. Hazen, Ulf Landmesser, Ursula Rauch, W.H. Wilson Tang, Mario Witkowski, Xinmin S. Li, Daniel Steffens, Ina Nemet, Julian Friebel and Arash Haghikia and has published in prestigious journals such as Nature Medicine, Circulation Research and International Journal of Molecular Sciences.

In The Last Decade

Marco Witkowski

26 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gut Microbiota and Cardiovascular Disease

2020 651 citations Marco Witkowski, Stanley L. Hazen et al. profile →
The artificial sweetener erythritol and cardiovascular event risk

2023 115 citations Marco Witkowski, Ina Nemet et al. Nature Medicine profile →
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk

2024 59 citations Marc Ferrell, Zeneng Wang et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marco Witkowski Germany	16	791	384	301	158	155	29	1.6k
Paweł Wołkow Poland	25	687 0.9×	326 0.8×	376 1.2×	335 2.1×	288 1.9×	106	2.0k
Ali Ramezani United States	16	935 1.2×	436 1.1×	119 0.4×	174 1.1×	122 0.8×	24	1.7k
Katharina Lechner Germany	19	295 0.4×	247 0.6×	164 0.5×	140 0.9×	140 0.9×	73	1.2k
Katsuyuki Tanabe Japan	22	537 0.7×	191 0.5×	131 0.4×	241 1.5×	192 1.2×	68	1.5k
Eman Abdel Rahman Ismail Egypt	22	265 0.3×	222 0.6×	130 0.4×	199 1.3×	137 0.9×	110	1.4k
Yunmei Yang China	24	638 0.8×	459 1.2×	117 0.4×	222 1.4×	139 0.9×	108	1.6k
Yuki Watanabe Japan	22	620 0.8×	228 0.6×	258 0.9×	281 1.8×	333 2.1×	106	1.7k
Jérémy Lagrange France	13	334 0.4×	218 0.6×	181 0.6×	76 0.5×	92 0.6×	42	805
Batya Kristal Israel	27	349 0.4×	259 0.7×	167 0.6×	280 1.8×	199 1.3×	73	1.9k
Mariano Janiszewski Brazil	17	628 0.8×	306 0.8×	174 0.6×	423 2.7×	152 1.0×	33	1.5k

Countries citing papers authored by Marco Witkowski

Since Specialization

Citations

This map shows the geographic impact of Marco Witkowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Witkowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Witkowski more than expected).

Fields of papers citing papers by Marco Witkowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Witkowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Witkowski. The network helps show where Marco Witkowski may publish in the future.

Co-authorship network of co-authors of Marco Witkowski

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Witkowski. A scholar is included among the top collaborators of Marco Witkowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Witkowski. Marco Witkowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Witkowski, Marco & Stanley L. Hazen. (2025). Xylitol and cardiovascular risks. European Heart Journal. 46(27). 2707–2708.

Witkowski, Marco, Ina Nemet, Xinmin S. Li, et al.. (2024). Xylitol is prothrombotic and associated with cardiovascular risk. European Heart Journal. 45(27). 2439–2452. 26 indexed citations

Witkowski, Marco, Jennifer Wilcox, Valesha M. Province, et al.. (2024). Ingestion of the Non-Nutritive Sweetener Erythritol, but Not Glucose, Enhances Platelet Reactivity and Thrombosis Potential in Healthy Volunteers—Brief Report. Arteriosclerosis Thrombosis and Vascular Biology. 44(9). 2136–2141. 10 indexed citations

Ferrell, Marc, Zeneng Wang, James T. Anderson, et al.. (2024). A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk. Nature Medicine. 30(2). 424–434. 59 indexed citations breakdown →

Witkowski, Marco & Stanley L. Hazen. (2024). Erythritol and xylitol and cardiovascular disease risk: a growing concern. European Heart Journal. 46(29). 2931–2932.

Witkowski, Marco, Ina Nemet, Hassan S. Alamri, et al.. (2023). The artificial sweetener erythritol and cardiovascular event risk. Nature Medicine. 29(3). 710–718. 115 indexed citations breakdown →

Witkowski, Marco, Max Wegner, Kai Jakobs, et al.. (2023). Intestinal Barrier Dysfunction and Microbial Translocation in Patients with First-Diagnosed Atrial Fibrillation. Biomedicines. 11(1). 176–176. 11 indexed citations

Witkowski, Marco, Ina Nemet, Hassan S. Alamri, et al.. (2023). The artificial sweetener erythritol and cardiovascular event risk. Yearbook of pediatric endocrinology. 1 indexed citations

Tang, W.H. Wilson, Ina Nemet, Xinmin S. Li, et al.. (2023). Prognostic Value of Gut Microbe-Generated Metabolite Phenylacetylglutamine in Patients with Heart Failure. European Journal of Heart Failure. 26(2). 233–241. 18 indexed citations

10.

Witkowski, Marco, Yuping Wu, W.H. Wilson Tang, & Stanley L. Hazen. (2023). NT-proBNP and cardiovascular event risk in individuals with prediabetes undergoing cardiovascular evaluation. Diabetes Research and Clinical Practice. 205. 110923–110923.

11.

Friebel, Julian, Marco Witkowski, Max Wegner, et al.. (2022). Cytotoxic CD8+ T Cells Are Involved in the Thrombo-Inflammatory Response during First-Diagnosed Atrial Fibrillation. Cells. 12(1). 141–141. 10 indexed citations

12.

Witkowski, Marco, Yuping Wu, Stanley L. Hazen, & W.H. Wilson Tang. (2021). Prognostic value of subclinical myocardial necrosis using high-sensitivity cardiac troponin T in patients with prediabetes. Cardiovascular Diabetology. 20(1). 171–171. 12 indexed citations

13.

Witkowski, Marco, Mario Witkowski, Julian Friebel, et al.. (2021). Vascular endothelial tissue factor contributes to trimethylamine N-oxide-enhanced arterial thrombosis. Cardiovascular Research. 118(10). 2367–2384. 72 indexed citations

14.

Witkowski, Marco, Julian Friebel, Andrea Dörner, et al.. (2020). Metformin Is Associated with Reduced Tissue Factor Procoagulant Activity in Patients with Poorly Controlled Diabetes. Cardiovascular Drugs and Therapy. 35(4). 809–813. 16 indexed citations

15.

Witkowski, Marco, Mario Witkowski, Mona Saffarzadeh, et al.. (2020). Vascular miR-181b controls tissue factor-dependent thrombogenicity and inflammation in type 2 diabetes. Cardiovascular Diabetology. 19(1). 20–20. 37 indexed citations

16.

Witkowski, Mario, Marco Witkowski, Nicola Gagliani, & Samuel Huber. (2017). Recipe for IBD: can we use food to control inflammatory bowel disease?. Seminars in Immunopathology. 40(2). 145–156. 31 indexed citations

17.

Witkowski, Marco & Ursula Rauch. (2016). Letter to the Editor: Tissue factor of endothelial origin: Just another brick in the wall?. Trends in Cardiovascular Medicine. 27(2). 155–156. 5 indexed citations

18.

Hisada, Yohei, Raj S. Kasthuri, Peter M. Voorhees, et al.. (2016). Measurement of microparticle tissue factor activity in clinical samples: A summary of two tissue factor-dependent FXa generation assays. Thrombosis Research. 139. 90–97. 64 indexed citations

19.

Steffens, Daniel, et al.. (2015). The effect of clopidogrel on platelet activity in patients with and without type-2 diabetes mellitus: a comparative study. Cardiovascular Diabetology. 14(1). 15–15. 38 indexed citations

20.

Witkowski, Marco, Ulf Landmesser, & Ursula Rauch. (2015). Tissue factor as a link between inflammation and coagulation. Trends in Cardiovascular Medicine. 26(4). 297–303. 177 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact